← Back to All Filings

HealthEquity CTO Sells $1.05M in Company Stock

Low SignificanceDecember 19, 2025 at 6:01:44 PM EST

HEALTHEQUITY, INC.

$HQY4CIK: 0001428336

Subscribe to track HQY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

HealthEquity CTO Sells $1.05M in Company Stock

Company: HEALTHEQUITY, INC. (HQY) Form: 4 | Filed: 2025-12-19 Significance: Low

Insider: Rosner Elimelech Title: EVP, CHIEF TECHNOLOGY OFFICER | Relationship: Officer

Transaction: • Type: Sell • Shares: 10,959 • Price: $95.45 • Value: $1,046,200 • Owned After: 45,742

Key Insight: The sale represents a very small fraction (0.013%) of the company's outstanding shares and is considered low significance.

Market Context: This transaction is a routine insider sale, unlikely to impact market sentiment for the $8.77B company.

Comprehensive Analysis

SEC Filing Analysis: HEALTHEQUITY, INC. (HQY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The EVP & Chief Technology Officer, Rosner Elimelech, sold $1.05 million worth of company stock, a transaction of low materiality relative to the company's size.
  • Market Impact: The sale is unlikely to have a material impact on the stock price due to its small size.

Company Information

FieldValue
CompanyHEALTHEQUITY, INC.
Ticker SymbolHQY
CIK0001428336
IndustrySERVICES-BUSINESS SERVICES, NEC

Insider Information

FieldValue
NameRosner Elimelech
CIK0001916312
Title/PositionEVP, CHIEF TECHNOLOGY OFFICER
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-18
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved10,959
Price Per Share$95.4549
Total Value$1,046,200
Shares Owned After45,742
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,046,200
% of Market Cap0.012%
Shares Transacted10,959
% of Shares Outstanding0.013%
Post-Transaction Ownership45,742 shares (0.053% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with an $8.77 billion market capitalization, this $1.05 million transaction is considered routine and financially immaterial.
  • Ownership Concentration: The sale represented approximately 19.3% of the insider's total holdings. While a notable portion of his personal stake, his remaining ownership at 0.053% of total shares outstanding is minimal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction's value is only 0.012% of the company's market cap, which is far too small to signal a significant change in insider sentiment or to influence the market.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The transaction size is unlikely to be noticeable against the stock's average daily trading volume.
  • Sentiment Indicator: Neutral. This is a standard insider transaction that does not provide a strong bullish or bearish signal.

Additional Context

Transaction Notes

  • Special Circumstances: The sale was conducted at a weighted average price, with individual transaction prices ranging from $95.40 to $95.67, as noted in the filing's footnotes. This is a common practice for executing larger orders to minimize market impact.
Topics:#SECFiling#InsiderTrading#HQY#HealthEquity#Form4#InsiderSell#StockMarket#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.